Abstract
Natural killer (NK) cells are lymphoid cells with spontaneous activity against a wide variety of tumor cell lines and against primary or metastatic tumor cells (1–3). It is now possible to isolate highly enriched populations of NK cells and demonstrate that this cytotoxic activity is mediated predominantly, if not solely, by a small subpopulation of lymphocytes, morphologically identified as large granular lymphocytes (LGL). In addition, a large proportion of LGL have NK activity (3,4). NK activity has been found to be positively regulated by a variety of agents, with the interferons and interleukin 2 (IL-2) being identified as the principal cytokines mediating this stimulation of reactivity (5).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
R. B. Herberman, and J. R. Ortaldo. Natural Killer cells: Their role in defenses against disease. Science 214:24, (1981).
J. R. Ortaldo, and R. B. Herberman. Heterogeneity of natural killer cells. Annu. Ref. Immunol. 2:359. (1984).
R. B. Herberman. Multiple functions of natural killer cells, including immunoregulation as well as resistance to tumor growth. Concepts Immunopathol. 1:96, (1985).
T. Timonen, J. R. Ortaldo, and R. B. Herberman. Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J. Exp. Med. 153:569, (1981).
R. B. Herberman, and A. Santoin. Regulation of natural killer (NK) cell activity. In Mihich, E. (Ed.): Biological Responses in Cancer, Vol. 2. New York, Pleunum Pub. Corp. New York, Plenum Publ. Corp. pp. 121–144, (1984).
T. Timonen, J. R. Ortaldo, B. M. Stadler, G. D. Bonnard, S. O. Sharrow, and R. B. Herberman. Cultures of purified human natural killer cells: Growth in the presence of interleukin 2. Cell Immunol. 72:178, (1982).
S. Yamada, F. W. Ruscetti, W. R. Overton, R. B. Herberman, and J. R. Ortaldo. Regulation of human large granular lymphocytes and T cell growth and function by recombinant interleukin 2. I. Induction of interleukin 2 receptor and promotion of growth of cells with enhance cytotoxicity. Manuscript submitted.
G. D. Bonnard, K. Yasaka, and D. Jacobson. Ligand-activated mitogenic factor-induced T-cell proliferation. Adsorption of mitogenic factor by activated T cells. J. Immunol. 123:2704–2708, (1979).
J. E. Talmadge, R. H. Wiltrout, D. F. Counts, R. B. Herberman, T. McDonald, and J. Ortaldo. Proliferation of human peripheral blood lymphocytes induced by recombinant human interleukin-2: Contribution of large granular lymphocytes and T lymphocytes. Manuscript submitted to Cell Immunology.
K. Itoh, A. B. Tilden, K. Kumagai, and C. M. Balch. Leu 11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (IL-2) included activated kill (AK) cells. J. Immunol. 134:802–807, (1985).
E. A. Grimm, R. J. Robb, J. A. Roth, L. M. Neckers, L. B. Lachman, D. J. Wilson, and S. A. Rosenberg. Lymphokine-activated killer cell phenomenon III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine activated killer cells. J. Exp. Med. 158:1356, (1983).
J. E. Ortaldo, A. T. Mason, J. P. Gerard, L. E. Henderson, W. Farrar, R. F. Hopkins III, R. B. Herberman, and H. Rabin. Effects of natural and recombinant IL-2 on regulation of IFN production and natural killer activity: Lack of involvement of the Tac antigen for these immunoregulatory effects. J. Immunol. 133:779, (1984).
R. B. Herberman. NK Cells and Other Natural Effector Cells. New York: Academic (1982).
R. B. Herberman, Calleweart, eds. Mechanisms of Cytotoxicity by NK Cells. Orlando, Fla: Academic (1985).
S. Targan, R. L. Deem, in R. B. Herberman and D. Calleweart, (eds). Mechanisms of Cytotoxicity by NK Cells. Orlando, Academic Press, Inc., p 155, (1985).
B. Perussia, O. Acuto, C. Terhorst, J. Faust, R. Lazaruz, V. Fanning, and G. Trinchieri. Human natural killer cells analyzed by B731.1, a monoclonal antibody blocking Fc receptor functions. J. Immunol. 130:2142, (1983).
C. W. Reynolds, S. O. Sharrow, J. R. Ortaldo, and R. B. Herberman. Natural killer (NK) activity in the rat. II. Analysis of surface antigens on LGL by flow cytometry. J. Immunol. 127:2204. (1981).
J. R. Ortaldo, S. O. Sharrow, T. Timonen, and R. B. Herberman. Determination of surface antigens on highly purified human NK cells by flow cytometry with monoclonal antibodies. J. Immunol. 127:2401. (1981).
R. Kiessling, E. Klein, H. Pross, and H. Wigzell. “Natural” killer cells in the mouse. II. Cutoptoxic cells with specificity for mouse Maloney leukemia cells. Characteristics of the killer cells. Eur. J. Immunol. 5:117, (1975).
J. C. Hiserodt, K. A. Laybourn and J. Varani. Expression of a laminin-like substance on the surface of murine natural killer (NK) lymphocytes and its role in NK recognition of tumor target cells. J. Immunol. 135:1484, (1985).
Y. Yanagi, N. Caccia, M. Kronenberg, B. Chin, J. Ropder, D. Rohel, T. Kiyohara, R. Lauzon, B. Toyanaga, O. K. Rosenthal, G. Dennert, H. Acha-Orbea, H. Hengartner, L. Hood, and T. W. Mak. Gene rearrangement in cells with natural killer activity and expression of the -chain of the T cell antigen receptor. Nature 314:631, (1985).
J. Ritz, T. J. Campen, R. E. Schmidt, H. D. Royer, T. Hercend, R. E. Hussey, and E. L. Reinherz. Analysis of T-cell receptor gene rearrangement and expression in human natural killer cell clones. Science 228:1540, (1985).
T. Hercend, S. C. Meuer, A. Brennan, M. A. Edson, O. Acuto, E. L. Reinherz, S. F. Schlossman, and J. Ritz. Identification of a clonally restricted 90 KID heterodimer on two cloned natural killer cell lines: its role cytotoxic effector function. J. Exp. Med. 158:1547, (1983).
C. W. Reynolds, M. Bonyhadi, R. B. Herberman, H. A. Young, and S. M. Hedrick. Lack of gene rearrangement and mRNA expression of the beta chain of the T cell receptor in spontaneous rat large granular lymphocyte leukemia lines. J. Exp. Med. 161:1249, (1985).
H. A. Young, J. R. Ortaldo, R. B. Herberman, and C. W. Reynolds. Analysis of T cell receptors in highly purified rat and human large granular lymphocytes (LGL): Lack of functional 1.3 kb large granular lymphocytes (LGL): Lack of functional 1.3 kb β-chain mRNA. J. Immunol. 137:2701–2704, (1986).
H. Binz, M. Fenner, D. Frei, and H. Wigzell. Two independent receptors allow selective target lysis by T cell clones. J. Exp. Med. 157:1252, (1983).
P. Allavena, A. Rambaldi, P. G. Palliocci, R. Della-Favera, and A. Mantovani. Immunolgical and genotype analysis of human large granular lymphocytes expansions. J. Leukocyte Biol. 38:59, (1985).
C. G. Brooks. Reversible induction of natural killer cell activity in clonal murine cytotoxic T lymphocytes. Nature 305:155, (1983).
P. A. Henkart, P. J. Willard, C. W. Reynolds, and M.P. Henkart. Cytolytic activity of purified cytoplasmic granules from cytotoxic rat LGL tumors. J. Exp. Med. 160:75, (1984).
C. W. Reynolds, E. W. Bere, and J. M. Ward. Natural killer activity in the rat. III. Characterization of transplantable large granular lymphocyte (LGL) leukemias in the F344 rat. J. Immunol. 132:534, (1984).
C. W. Reynolds, D. Reichardt, M. Henkart, P. Millard, and P. Henkart. Inhibition of NK and ADCC activity by antibodies against purified cytoplasmic granules from rat LGL tumors. J. Exp. Med. in press.
S. C. Wright, and B. Bonavida. Studies on the mechanism of natural killer (NK) cell-mediated cytotoxicity (CMC). I. Release of cytotoxic factors specific for NK-sensitive target cells (NKCF) during co-culture of NK effector cells with NK target cells. J. Immunol. 129:433, (1982).
J. R. Ortaldo, I. Bianca, and R. B. Herberman. Studies of human natural killer cytotoxic factor (NKCF); Characterization and analysis of its mode of action. In P. Henkart, E. Martz, eds. Mechanisms of Cell-Mediated Cytotoxicity. New York: Plenum. 203 pp (1985).
I. Bianca, R. B. Herberman, and J. R. Ortaldo. Human natural killer cytotoxic factor. Natural Immunity Cell Growth Resul. 4:48, (1985).
J. E. Blalock, J. A. Georgiades, N. F. Langford, and H. M. Johnson. Purified human immune interferon has more potent anticellular activity than fibroblast or leukocyte interferon. Cell Immunol. 49:390, (1980).
B. B. Aggarwal, W. J. Henzel, B. Moffat, W. J. Kohn, and R. N. Harkins. Primary structure of human lymphotoxin derived from 1788 lymphoblastoid cell line. J. Biol. Chem. 260:2334. (1985).
E. A. Carswell, L. J. Old, R. L. Kassel, S. Green, N. Fiore, and N. Williamson. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 72:P3666. (1975).
D. Pennica, G. W. Nedwin, J. S. Hayflick, P. H. Seeburg, R. Derynck, M. A. Paladino, W. J. Kohr, B. B. Aggarwal, and D. V. Goeddel. Human tumor necrosis factor: Precursor structure, expression and homology to lymphotoxin. Nature 312:724, (1984).
J. H. Ransom, C. H. Evans, R. P. McCabe, N. Pomato, J. A. Heinbaugh, M. Chin, and M. G. Hanna Jr. Leukoregulin, a direct-acting anticancer immunological hormone that is distinct from lymphotoxin and interferon. Cancer Res. 45:851, (1985).
O. Stutman, C. J. Paige, and E. F. Figarella. Natural cytotoxic cells against solid tumors in mice. I. Strain and age distribution and target cell susceptibility. J. Immunol. 121:1819, (1978).
J. R. Ortaldo, L. H. Mason, B. J. Mathieson, S. M. Liang, D. A. flick, and R. B. Herberman. Mediation of mouse natural cytotoxic (NC) activity by tumor necrosis factor (TNF). Nature in press.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Press, New York
About this chapter
Cite this chapter
Herberman, R.B. (1987). Activation of Natural Killer (NK) Cells and Mechanism of Their Cytotoxic Effects. In: Gupta, S., Paul, W.E., Fauci, A.S. (eds) Mechanisms of Lymphocyte Activation and Immune Regulation. Advances in Experimental Medicine and Biology, vol 213. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5323-2_27
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5323-2_27
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5325-6
Online ISBN: 978-1-4684-5323-2
eBook Packages: Springer Book Archive